Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 2, 2022
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
Mon, August 1, 2022
[ Mon, Aug 01st 2022
] - WOPRAI
Balaji Prasad Initiated (TARS) at Buy and Held Target at $40 on, Aug 1st, 2022
Balaji Prasad of Barclays, Initiated "Tarsus Pharmaceuticals, Inc." (TARS) at Buy and Held Target at $40 on, Aug 1st, 2022.
Balaji, nor any peers, have made any analyst calls on TARS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30